Serafin, Andrea. 2026. “P065 | Clinical and Genomic Patterns of Disease Progression in CLL Patients Treated With Fixed-Duration <i>versus</i> Continuous Targeted Therapies: <a href="https://haematologica.org/search/search?query=A.+Serafin">A. Serafin</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=F.+Angotzi">F. Angotzi</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=A.+Bevilacqua">A. Bevilacqua</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=A.+Cellini">A. Cellini</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=M.+D’antiga">M. D’antiga</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=L.+Bonaldi">L. Bonaldi</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=A.+Martines">A. Martines</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=E.+Albi">E. Albi</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=E.+Sant’antonio">E. Sant’antonio</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=F.+Martini">F. Martini</a><sup>3</sup>, <a href="https://haematologica.org/search/search?query=S.+De+Antoni">S. De Antoni</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=S.+Pepe">S. Pepe</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=I.+Cavallari">I. Cavallari</a><sup>2</sup>, <a href="https://haematologica.org/search/search?query=A.+Noto">A. Noto</a><sup>5</sup>, <a href="https://haematologica.org/search/search?query=A.M.+Frustaci">A.M. Frustaci</a><sup>5</sup>, <a href="https://haematologica.org/search/search?query=F.R.+Mauro">F.R. Mauro</a><sup>4</sup>, <a href="https://haematologica.org/search/search?query=P.+Ghia">P. Ghia</a><sup>3|6</sup>, <a href="https://haematologica.org/search/search?query=L.+Scarfò">L. Scarfò</a><sup>3|6</sup>, <a href="https://haematologica.org/search/search?query=L.+Trentin">L. Trentin</a><sup>1</sup>, <a href="https://haematologica.org/search/search?query=A.+Visentin">A. Visentin</a><sup>1</sup> | <i><sup>1</sup>Hematology Unit, Department of Medicine, University of Padova; <sup>2</sup>Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV-IRCSS; <sup>3</sup>Strategic Research Program on CLL, IRCCS Ospedale San Raffaele; <sup>4</sup>Hematology, Department of Translational and Precision Medicine, "Sapienza" University; <sup>5</sup>Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda; <sup>6</sup>Medical School, Università Vita-Salute San Raffaele</I&gt;”. Haematologica 111 (s1). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s1.130.